Charles River Laboratories
251 Ballardvale Street
Wilmington
MA
01887
United States
(781) 222-6000
Product(s):
Provides essential research products and services that advance drug discovery and development
Employees:
8700
Established:
1947
Ownership:
Public
Exchange:
NYSE
symbol:
CRL
2004 Revenue:
$766,917,000
2005 Revenue:
$1,122,228,000
2006 Revenue:
$1,058,385,000
2007 Revenue:
$1,230,626,000
2008 Revenue:
$1,343,493,000
Yahoo Quotes:
CEO:
James C. Foster, CEO, President, Chairman Management:
Thomas F. Ackerman, Corp. EVP, CFO
Christophe Berthoux, Corp. EVP-Global Sales and Marketing, CCO
Permalink
RECENT BLOG POSTS
- Is Valeant About To Make A Bold Bid For Bausch & Lomb?
- When regulators are ignored
- FDA Issues Draft Guidance to Help Companies Distinguish Between a Voluntary Medical Device Recall and a Product Enhancement
- Patient and family engagement in ICUs
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
